Climate change is driving drastic environmental shifts and accelerating global biodiversity loss. Hybrid introgression has ...

Studying the ways that magenta and yellow flowers intermingle paints a vibrant picture of how the plants exchange genetic ...

Thinking about CRISPR Therapeutics and wondering if now is your chance to scoop up value, or if the stock is already priced in with the excitement? Let's break down what the numbers and news say about ...

New research posits that a genetic incompatibility between female offspring of humans and Neanderthals and their children could have led to pregnancy complications and the eventual end of the species ...

While the exact causes of neurodegenerative brain diseases like Alzheimer's and dementia are still largely unknown, ...

Researchers from the Indiana University School of Medicine have developed a highly sensitive diagnostic that predicts a ...

A sweeping new genetic study has uncovered a long-overlooked thread in the fabric of South American history: a deeply rooted ...

Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...

Another surprising finding from this study concerns the ancient Jomon people from the Japanese archipelago and the ...

Repligen Corporation ( RGEN) UBS Global Healthcare Conference 2025 November 10, 2025 11:00 AM EST All right. With that, we're ready to kick things off. Next up, we have Repligen. Representing the ...

A Human Immune Health Atlas, mapping 71 different immune cells and their changes over time, was released to support studies into the aging immune system.

Bionano Genomics, Inc. (NASDAQ: BNGO) Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats ...